BHEKISISA Drugmakers to sell 6-monthly anti-HIV jab for the price of the daily HIV prevention pill 7 min 0 By Mia Malan
MEDICINE INEQUITIES OP-ED How South Africa can help secure immediate, global access to HIV prevention drug lenacapavir 5 min 1 By Tian Johnson, Fatima Hassan, Asia Russell and Sangeeta Shashikant
BHEKISISA Talks have started to get the twice-yearly anti-HIV jab registered in SA 3 min 1 By Mia Malan
BHEKISISA Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa 9 min 0 By Mia Malan and Linda Pretorius
OP-ED A redeeming moment for the SA government: A case for compulsory licensing in the age of Covid-19 6 min 0 By Fatima Hassan
